US Patent 12433891 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

U.S. Patents

PharmaCompass Sponsored Ads

Post An Enquiry

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

PharmaCompass Sponsored Ads

Post An Enquiry

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Xls

CATEGORY PAGE

Filters

FILTER :

filter Applicant Reset all filters

36 All

01 36HANDA THERAP

filter Patent Number Reset all filters

36 All

01 3612433891

API Patent Reset all filters

36 All

01 36Blank

FDF Patent Reset all filters

36 All

01 36Blank

filter Expiration Date Reset all filters

36 All

01 362041-01-22

01

HANDA THERAP

BePharma

Not Confirmed

HANDA THERAP

Country

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-01-22

US Patent Number : 12433891

Drug Substance Claim :

Drug Product Claim :

Application Number : 216099

Patent Use Code : U-3769

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

HANDA THERAP

BePharma

Not Confirmed

HANDA THERAP

Country

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-01-22

US Patent Number : 12433891

Drug Substance Claim :

Drug Product Claim :

Application Number : 216099

Patent Use Code : U-3770

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

HANDA THERAP

BePharma

Not Confirmed

HANDA THERAP

Country

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-01-22

US Patent Number : 12433891

Drug Substance Claim :

Drug Product Claim :

Application Number : 216099

Patent Use Code : U-3770

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

HANDA THERAP

BePharma

Not Confirmed

HANDA THERAP

Country

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-01-22

US Patent Number : 12433891

Drug Substance Claim :

Drug Product Claim :

Application Number : 216099

Patent Use Code : U-3768

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

HANDA THERAP

BePharma

Not Confirmed

HANDA THERAP

Country

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-01-22

US Patent Number : 12433891

Drug Substance Claim :

Drug Product Claim :

Application Number : 216099

Patent Use Code : U-3771

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

HANDA THERAP

BePharma

Not Confirmed

HANDA THERAP

Country

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-01-22

US Patent Number : 12433891

Drug Substance Claim :

Drug Product Claim :

Application Number : 216099

Patent Use Code : U-3768

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

HANDA THERAP

BePharma

Not Confirmed

HANDA THERAP

Country

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-01-22

US Patent Number : 12433891

Drug Substance Claim :

Drug Product Claim :

Application Number : 216099

Patent Use Code : U-3767

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

HANDA THERAP

BePharma

Not Confirmed

HANDA THERAP

Country

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-01-22

US Patent Number : 12433891

Drug Substance Claim :

Drug Product Claim :

Application Number : 216099

Patent Use Code : U-3772

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

HANDA THERAP

BePharma

Not Confirmed

HANDA THERAP

Country

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-01-22

US Patent Number : 12433891

Drug Substance Claim :

Drug Product Claim :

Application Number : 216099

Patent Use Code : U-3767

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

HANDA THERAP

BePharma

Not Confirmed

HANDA THERAP

Country

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2041-01-22

US Patent Number : 12433891

Drug Substance Claim :

Drug Product Claim :

Application Number : 216099

Patent Use Code : U-3772

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-01-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.